TheraRadar
← Back
Data updated: Jun 28, 2026

STRIDES PHARMA GLOBAL PTE LIMITED

Pharma
Pharmaceuticals

STRIDES PHARMA GLOBAL PTE LIMITED is a pharmaceutical company with 1 FDA-approved products.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

STRIDES PHARMA GLOBAL PTE LIMITED's Key Drugs

STRIDES PHARMA GLOBAL PTE LIMITED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

STRIDES PHARMA GLOBAL PTE LIMITED's Recent FDA Approvals

New NDA/BLA approvals for STRIDES PHARMA GLOBAL PTE LIMITED over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

STRIDES PHARMA GLOBAL PTE LIMITED's Therapeutic Areas

Disease areas where STRIDES PHARMA GLOBAL PTE LIMITED has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

STRIDES PHARMA GLOBAL PTE LIMITED Pipeline Snapshot

Active clinical trials for STRIDES PHARMA GLOBAL PTE LIMITED across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling